Products
Tools
Education
$5.32
$4.97
$6.35
$0.94
$274.4M
441.93%
This is a preview of the full version of Prosperse
Tempus AI, a niche AI company, has increased its stake in Personalis, a biotech firm specializing in cancer diagnostics. The move has led to a significant surge in Tempus AI's stock price, outperforming the broader market.
Eric Volkman
Aug 21, 2024
Date: Oct 25, 2024
Date: Oct 24, 2024